McKinsey January 8, 2021
Biopharma in 2020 has shown what it can achieve when it works at its best. How can the industry build on this renewed sense of purpose in the years ahead?
More than any year in living memory, 2020 has tested the tenacity and ingenuity of the human spirit. The most devastating pandemic in memory has cost more than 1.5 million lives to date and produced the most profound economic shock since World War II. After almost a year, the COVID-19 pandemic is still raging across the globe, claiming more than a million new cases every other day. The search for vaccines and therapies has been the most urgent and widespread the world has ever seen.
...
Today's Sponsors
Today's Sponsor